tofacitinib우선순위 낮음근거 검토기타
LITERATURE DETAIL · PMID 42554830
Development and Validation of Sustainable RP-HPLC Method for Tofacitinib Quantification in MCM-41 and MCM-48 Silica Nanoparticles and its In-vitro Application.
Development and Validation of Sustainable RP-HPLC Method for Tofacitinib Quantification in MCM-41 and MCM-48 Silica Nanoparticles and its In-vitro Application.
- 저자
- Vidhi S Pandya, Nidhi R Trivedi, Manish N Nandpal, Meghana N Patel, Bhupendra G Prajapati, Amit A Patel
- 저널
- Journal of AOAC International
- 공개일
- 2026 Aug 05
- 연구 유형
- 기타
- DOI
- 10.1093/jaoacint/qsag073
문헌 요약
Tofacitinib is a Janus kinase inhibitor approved by the FDA, for the treatment of autoimmune disorders. The research aimed to develop, validate, and apply a simple, rugged, and environmentally sustainable RP-HPLC method for the quantitative estimation of Tofacitinib in in-house developed Mesoporous Silica Nanoparticles (MCM-41 and MCM-48), intended for fo…
PV 검토 포인트
누적 안전성 근거로 분류하고 기존 시그널과의 일관성을 확인합니다.